Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
0.530
+0.017 (3.37%)
At close: Jan 17, 2025, 4:00 PM
0.515
-0.015 (-2.81%)
After-hours: Jan 17, 2025, 7:37 PM EST
Onconetix Revenue
Onconetix had revenue of $406.86K in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $1.87M. In the year 2023, Onconetix had annual revenue of $58.47K.
Revenue (ttm)
$1.87M
Revenue Growth
n/a
P/S Ratio
0.21
Revenue / Employee
$155,884
Employees
12
Market Cap
4.40M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 58.47K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 87.70B |
| Merck & Co. | 63.17B |
| AbbVie | 55.53B |
| AstraZeneca | 51.21B |
| Novartis AG | 49.94B |
| Thermo Fisher Scientific | 42.37B |
| Abbott Laboratories | 41.22B |
ONCO News
- 5 weeks ago - Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing - GlobeNewsWire
- 3 months ago - Virometix appoints Christina Ackermann as Chair and Tim Ramdeen as member of the Board - Business Wire
- 3 months ago - Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit - GlobeNewsWire
- 3 months ago - Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit - GlobeNewsWire
- 4 months ago - Crude Oil Rises; Onconetix Shares Spike Higher - Benzinga
- 4 months ago - Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of Stockholders - GlobeNewsWire
- 6 months ago - Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds - GlobeNewsWire
- 6 months ago - Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds - GlobeNewsWire